opioid-induced constipation
opioid-induced constipation
Explore linked clinical trials. Standard reference: MONDO:01001876 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Prevention of Opioid-induced Constipation in Patients With Advanced Cancer | Cancer Pain, Chemically-Induced Disorders, Narcotic-Related Disorders, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, constipation disorder, neoplasm, opioid-induced constipation, psychiatric disorder, substance-related disorder | Recruiting | Phase 4 | 2026-10-05 | NCT05216328 | |
| Risk of Major Adverse Cardiovascular Events for Naldemedine & Other Medications for Opioid Induced Constipation | Chemically-Induced Disorders, Narcotic-Related Disorders, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, constipation disorder, opioid-induced constipation, psychiatric disorder, substance-related disorder | Recruiting | Not stated | 2026-09-30 | NCT03720613 | |
| Safety and Pharmacokinetics Study of Naldemedine in Paediatric Participants Receiving Opioids | Chemically-Induced Disorders, Narcotic-Related Disorders, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, constipation disorder, opioid-induced constipation, psychiatric disorder, substance-related disorder | Recruiting | Phase 1 / Phase 2 | 2026-07-28 | NCT05588323 | |
| A Prospective, Multicenter, Randomized, Parallel-controlled, Superiority Trial | opioid-induced constipation | Not yet recruiting | Phase 3 | 2026-04-27 | NCT07534995 | |
| Naldemedine in Clinical Practice in Cancer Patients With Opioid Induced CONstipation: Clinical Outcomes and Patient Experience | Chemically-Induced Disorders, Narcotic-Related Disorders, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, cancer, constipation disorder, neoplasm, opioid-induced constipation, psychiatric disorder, substance-related disorder | Recruiting | Not stated | 2026-01-02 | NCT07231796 | |
| Real World Study of Oxycodone/Naloxone Sustained-Release Tablets (Mimeixin) for Patients With Severe Cancer Pain | Cancer Pain, Chemically-Induced Disorders, Narcotic-Related Disorders, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, constipation disorder, opioid-induced constipation, psychiatric disorder, substance-related disorder | Not yet recruiting | Phase 4 | 2025-03-27 | NCT06897917 |